Traditional Chinese medicine formula for treating respiratory system infectious diseases and pulmonary interstitial fibrosis

A technology for pulmonary interstitial fibrosis and infectious diseases, applied to respiratory diseases, medical formulas, medical preparations containing active ingredients, etc., to achieve the effects of wide application, convenient use, and medical cost savings

Inactive Publication Date: 2021-05-14
新疆医科大学第四附属医院
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Treatment of pulmonary fibrosis caused by chronic diseases of the respiratory system, infectious diseases, and new-type coronavirus pneumonia, etc., usually with fatigue, pale complexion, dry mouth and throat, emaciated body, patients with both qi and yin injuries, and red tongue coating Few, deep pulse or fine count, the new type of coronavirus pneumonia is caused by the infection of the new type of coronavirus (COVID-19). For the above symptoms, there is currently a lack of traditional Chinese medicine preparations with small side effects, easy to take and carry, low cost and obvious effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine formula for treating respiratory system infectious diseases and pulmonary interstitial fibrosis
  • Traditional Chinese medicine formula for treating respiratory system infectious diseases and pulmonary interstitial fibrosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1, a traditional Chinese medicine formula for treating respiratory infectious diseases and pulmonary interstitial fibrosis, the raw materials of traditional Chinese medicine are proportioned according to the following parts by weight: 12-30 parts of Radix Astragali, 15-21 parts of Dendrobium, 15 parts of Honeysuckle -21 copies.

[0016] Through the clinical use of 68 patients with new coronary pneumonia, the present invention found that: 1. After taking traditional Chinese medicine for 4-6 days, the symptoms of shortness of breath, fatigue and sweating were alleviated; The toxic and side effects of western medicine have improved the immunity of patients; 4. None of the patients treated became critically ill.

[0017] The following table is as follows for individual case patients after taking the Chinese medicine of the Chinese medicine formula of the present invention:

[0018]

[0019]

Embodiment 2

[0020] In Example 2, the raw materials of traditional Chinese medicine are proportioned according to the following parts by weight: 20-30 parts of Radix Astragali, 18-21 parts of Dendrobium, and 18-21 parts of Honeysuckle.

Embodiment 3

[0021] Embodiment 3, the raw materials of traditional Chinese medicine are proportioned according to the following parts by weight: 20 parts of Radix Astragali, 18 parts of Dendrobium, and 18 parts of Flos Lonicerae.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine formula for treating respiratory system infectious diseases and pulmonary interstitial fibrosis, and the traditional Chinese medicine raw materials comprise, by weight, 12-30 parts of astragalus membranaceus, 15-21 parts of dendrobe and 15-21 parts of honeysuckle. The traditional Chinese medicine composition is remarkable in effect, small in side effect and wide in applicable crowd, and can effectively shorten the recovery time of patients, improve the symptoms of the patients, promote lung inflammation absorption, prevent and improve the occurrence and progress of pulmonary fibrosis and effectively prevent the illness state of asymptomatic infectors or mild new coronavirus pneumonia patients from being changed into severe or critical illness states.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine formula for treating respiratory infectious diseases and pulmonary interstitial fibrosis. Background technique [0002] Treatment of pulmonary fibrosis caused by chronic diseases of the respiratory system, infectious diseases, and new-type coronavirus pneumonia, etc., usually with fatigue, pale complexion, dry mouth and throat, emaciated body, patients with both qi and yin injuries, and red tongue coating Few, deep pulse or fine count, the new type of coronavirus pneumonia is caused by the infection of the new type of coronavirus (COVID-19). Injury, for the above symptoms, there is a lack of small side effects, easy to take and carry, low cost and effective traditional Chinese medicine preparations. Contents of the invention [0003] In view of the above problems, the purpose of the present invention is to provide a drug wit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8984A61P11/00A61P31/14
CPCA61K36/286A61K36/355A61K36/42A61K36/481A61K36/65A61K36/71A61K36/8984A61P11/00A61P31/14A61K2300/00
Inventor 李风森荆晶李争马红霞徐丹王丽霞徐倩聂继红赵翡翠李茜
Owner 新疆医科大学第四附属医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap